| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Low density lipoprotein receptor (LDLR) from ORIGENE TECHNOLOGIES | LY400183 | 100 ug | ORIGENE TECHNOLOGIES |
| Low density lipoprotein receptor (LDLR), transcript variant 4 from ORIGENE TECHNOLOGIES | LY434377 | 100 ug | ORIGENE TECHNOLOGIES |
| Low density lipoprotein receptor (LDLR), transcript variant 6 from ORIGENE TECHNOLOGIES | LY434371 | 100 ug | ORIGENE TECHNOLOGIES |
| Low density lipoprotein receptor-related protein 8, apolipoprotein e receptor (LRP8), transcript variant 3 from ORIGENE TECHNOLOGIES | LY413735 | 100 ug | ORIGENE TECHNOLOGIES |
| Low density lipoprotein receptor-related protein 8, apolipoprotein e receptor (LRP8), transcript variant 4 from ORIGENE TECHNOLOGIES | LY422708 | 100 ug | ORIGENE TECHNOLOGIES |
| Low density lipoprotein receptor-related protein associated protein 1 (LRPAP1) from ORIGENE TECHNOLOGIES | LY419397 | 100 ug | ORIGENE TECHNOLOGIES |
| AKAP12 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN214439 | 1 kit | ORIGENE TECHNOLOGIES |
| AKAP12 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN214439RB | 1 kit | ORIGENE TECHNOLOGIES |
| AKAP12 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN214439LP | 1 kit | ORIGENE TECHNOLOGIES |
| AKAP2 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN217988 | 1 kit | ORIGENE TECHNOLOGIES |
| AKAP12 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN214439BN | 1 kit | ORIGENE TECHNOLOGIES |
| AKAP2 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN217988BN | 1 kit | ORIGENE TECHNOLOGIES |
| AKAP2 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN217988LP | 1 kit | ORIGENE TECHNOLOGIES |
| AKAP2 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN217988RB | 1 kit | ORIGENE TECHNOLOGIES |
| Anaphase promoting complex subunit 10 (ANAPC10) from ORIGENE TECHNOLOGIES | LY414956 | 100 ug | ORIGENE TECHNOLOGIES |
| Anaphase promoting complex subunit 2 (ANAPC2) from ORIGENE TECHNOLOGIES | LY402247 | 100 ug | ORIGENE TECHNOLOGIES |
| Anaphase promoting complex subunit 11 (ANAPC11), transcript variant 1 from ORIGENE TECHNOLOGIES | LY424181 | 100 ug | ORIGENE TECHNOLOGIES |
| Anaphase promoting complex subunit 11 (ANAPC11), transcript variant 2 from ORIGENE TECHNOLOGIES | LY413973 | 100 ug | ORIGENE TECHNOLOGIES |
| Anaphase promoting complex subunit 11 (ANAPC11), transcript variant 3 from ORIGENE TECHNOLOGIES | LY424182 | 100 ug | ORIGENE TECHNOLOGIES |
| Anaphase promoting complex subunit 11 (ANAPC11), transcript variant 4 from ORIGENE TECHNOLOGIES | LY424183 | 100 ug | ORIGENE TECHNOLOGIES |
| Anaphase promoting complex subunit 11 (ANAPC11), transcript variant 3 from ORIGENE TECHNOLOGIES | LY425074 | 100 ug | ORIGENE TECHNOLOGIES |
| Anaphase promoting complex subunit 11 (ANAPC11), transcript variant 4 from ORIGENE TECHNOLOGIES | LY425075 | 100 ug | ORIGENE TECHNOLOGIES |
| Anaphase promoting complex subunit 11 (ANAPC11), transcript variant 5 from ORIGENE TECHNOLOGIES | LY424184 | 100 ug | ORIGENE TECHNOLOGIES |
| Anaphase promoting complex subunit 11 (ANAPC11), transcript variant 6 from ORIGENE TECHNOLOGIES | LY424185 | 100 ug | ORIGENE TECHNOLOGIES |
| Anaphase promoting complex subunit 11 (ANAPC11), transcript variant 6 from ORIGENE TECHNOLOGIES | LY425076 | 100 ug | ORIGENE TECHNOLOGIES |
| Anaphase promoting complex subunit 11 (ANAPC11), transcript variant 7 from ORIGENE TECHNOLOGIES | LY424186 | 100 ug | ORIGENE TECHNOLOGIES |
| Anaphase promoting complex subunit 5 (ANAPC5), transcript variant 1 from ORIGENE TECHNOLOGIES | LY402524 | 100 ug | ORIGENE TECHNOLOGIES |
| Anaphase promoting complex subunit 11 (ANAPC11), transcript variant 7 from ORIGENE TECHNOLOGIES | LY425077 | 100 ug | ORIGENE TECHNOLOGIES |
| Anaphase promoting complex subunit 7 (ANAPC7), transcript variant 1 from ORIGENE TECHNOLOGIES | LY414102 | 100 ug | ORIGENE TECHNOLOGIES |
| Anaphase promoting complex subunit 13 (ANAPC13), transcript variant 1 from ORIGENE TECHNOLOGIES | LY414554 | 100 ug | ORIGENE TECHNOLOGIES |
| Anaplastic lymphoma receptor tyrosine kinase (ALK) from ORIGENE TECHNOLOGIES | LY418072 | 100 ug | ORIGENE TECHNOLOGIES |
| MALSU1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN404263 | 1 kit | ORIGENE TECHNOLOGIES |
| Malsu1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN509685 | 1 kit | ORIGENE TECHNOLOGIES |
| Mal, T-cell differentiation protein-like (MALL) from ORIGENE TECHNOLOGIES | LY417304 | 100 ug | ORIGENE TECHNOLOGIES |
| Mal, T-cell differentiation protein 2 (MAL2) from ORIGENE TECHNOLOGIES | LY409397 | 100 ug | ORIGENE TECHNOLOGIES |
| Mal, T-cell differentiation protein (MAL), transcript variant a from ORIGENE TECHNOLOGIES | LY400850 | 100 ug | ORIGENE TECHNOLOGIES |
| Mal, T-cell differentiation protein (MAL), transcript variant b from ORIGENE TECHNOLOGIES | LY411702 | 100 ug | ORIGENE TECHNOLOGIES |
| Mal, T-cell differentiation protein (MAL), transcript variant d from ORIGENE TECHNOLOGIES | LY411704 | 100 ug | ORIGENE TECHNOLOGIES |
| Mal, T-cell differentiation protein (MAL), transcript variant b from ORIGENE TECHNOLOGIES | LY429682 | 100 ug | ORIGENE TECHNOLOGIES |
| Mal, T-cell differentiation protein (MAL), transcript variant d from ORIGENE TECHNOLOGIES | LY429684 | 100 ug | ORIGENE TECHNOLOGIES |
| MALT1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN204322 | 1 kit | ORIGENE TECHNOLOGIES |
| MALT1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN204322BN | 1 kit | ORIGENE TECHNOLOGIES |
| Human insulin-like growth factor binding protein 4 (IGFBP4) from ORIGENE TECHNOLOGIES | TP720301 | 10 ug | ORIGENE TECHNOLOGIES |
| Human insulin-like growth factor binding protein 4 (IGFBP4) from ORIGENE TECHNOLOGIES | TP304188 | 20 ug | ORIGENE TECHNOLOGIES |
| Human insulin-like growth factor binding protein 6 (IGFBP6) from ORIGENE TECHNOLOGIES | TP304060 | 20 ug | ORIGENE TECHNOLOGIES |
| Human insulin-like growth factor binding protein 7 (IGFBP7) from ORIGENE TECHNOLOGIES | TP309844 | 20 ug | ORIGENE TECHNOLOGIES |
| Human insulin-like growth factor binding protein 1 (IGFBP1) from ORIGENE TECHNOLOGIES | TP309268 | 20 ug | ORIGENE TECHNOLOGIES |
| Human insulin-like growth factor binding protein 1 (IGFBP1). from ORIGENE TECHNOLOGIES | TP723169 | 25 ug | ORIGENE TECHNOLOGIES |
| Human insulin-like growth factor binding protein 4 (IGFBP4). from ORIGENE TECHNOLOGIES | TP723172 | 20 ug | ORIGENE TECHNOLOGIES |
| Human insulin-like growth factor binding protein 5 (IGFBP5) from ORIGENE TECHNOLOGIES | TP721046 | 10 ug | ORIGENE TECHNOLOGIES |